None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Inclusion criteria a) 18-64 years old b) Diagnosed with anxiety disorder, trauma, and stress-related disorders (all diagnoses are based on DSM-5) c) Be able to understand the content of the consent form and ha ve verbal and cognitive abilities enough to respond to the questio nnaires and operate the VR devices/programs d) Can fully understand the detailed explanation regarding this st udy and voluntarily agree to participate in this study
Exclusion criteria
Exclusion criteria: (2) Exclusion criteria a) Those diagnosed with AXIS I other than anxiety disorder, trauma and stress-related disorder b) Those diagnosed with bipolar or psychotic disorder c) Those diagnosed with alcohol abuse and alcohol dependence d) Those who attempted suicide within 6 months from the screening date e) Those judged to have problems with EEG and electrode attachment due to scalp deformity, inflammatory reaction or other dermatological problems f) Those with a history of epileptic (epileptic) seizures or photosensitive seizures g) Those who experienced severe dizziness, eye or convulsions or temporary loss of consciousness due to flashes or patterns h) Those with organic brain abnormalities such as Parkinson's disease or cerebrovascular disease i) Those with clinically serious disorders in the cardiovascular, digestive, respiratory, endocrine, or central nervous systems j) Those with abnormal binocular vision k) In order to prevent the spread of infectious diseases (conjunctivitis), those with infectious symptoms, infections or diseases, or especially Those with infectious symptoms or diseases of the eyes, skin or scalp l) Pregnant women or breastfeeding women m) In addition to the above, those with clinically significant findings that the test director or person in charge deems inappropriate for this test based on medical judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Posttraumatic Diagnosis Scale;Visual Analogue Scale for Anxiety;State Anxiety Inventory-1 | — |
Secondary
| Measure | Time frame |
|---|---|
| Trait Anxiety Inventory-2;The Center for Epidemiologic Studies Depression Scale;Multidimensional Assessment of Interoceptive Awareness;3D Presence/Fatigue;Electroencephalography;Functional Near-Infrared Spectroscopy;Heart Rate Variability | — |
Countries
Korea, Republic of
Contacts
Hallym University Medical Center- Chuncheon